Ruplizumab (BG 9588) is a humanized IgG1?? monoclonal antibody targeting CD40 ligand (CD40L), a member of the TNF receptor superfamily. This antibody is designed for the investigation of its therapeutic potential in systemic lupus erythematosus (SLE). Ruplizumab may facilitate the study of CD40L interactions and signaling pathways in immune response regulation, providing insights into the pathogenesis and treatment of SLE.
Ruplizumab (BG 9588) is a humanized IgG1?? monoclonal antibody targeting CD40 ligand (CD40L), a member of the TNF receptor superfamily. This antibody is designed for the investigation of its therapeutic potential in systemic lupus erythematosus (SLE). Ruplizumab may facilitate the study of CD40L interactions and signaling pathways in immune response regulation, providing insights into the pathogenesis and treatment of SLE.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
